Blog
News

Health Care Week In Review: The Cloud Enables Innovation for the Pharmaceutical Industry, The FCC is Developing a Pilot Program to Support Patient Access to Telehealth and Remote-Monitoring Services, Air Pollution Can be Just as Harmful as Smoking

HealthcareITNews

Here's The Latest in Health Care:

•  Cloud-based technologies can give pharmaceutical companies access to greater resources and more data, which could have a large positive impact on the industry. According to Dr. Larry Ponemon, the founder and chairman of the Ponemon Institute, the shift to a cloud environment could have positive impacts on data security, supply chain processes, and artificial intelligence innovations. Even so, there’s still a divide when it comes to seeing the value in public clouds, as many harbor security concerns.  Read More

•  The Federal Communications Commission is developing a new program to support telehealth and remote patient-monitoring services to improve access to care in underserved populations such as low-income patients and veterans. The three-year, $100 million Connected Care Pilot program plans to cover up to 85% of the broadband internet cost needed for telehealth services, giving patients better access to their doctors. The pilot program aims to provide treatment for patients in rural and disadvantaged areas whose difficulty in accessing a broadband internet connection previously made telehealth an unattainable option.  Read More

•  A new study has found that moderate levels of air pollution can potentially cause just as much damage to lung function as smoking does. Researchers found that each increase in five micrograms per cubic meter in PM2.5, tiny pollutant particles that can be damaging to one’s health, resulted in a 52 percent increase in chronic obstructive pulmonary disease. The effects of moderate air pollution were also found to be four times more harmful than secondhand smoke.  
Read More

•  A new study found that outcomes for patients suffering from opioid use disorders have improved since the launch of CMS’ April 2018 initiative to reduce preauthorization requirements for buprenorphine, the most common drug used for treating opioid addiction. Research found that the percentage of Part D and Medicare Advantage insurance plans that required prior authorizations dropped tremendously from 87.5% in 2017 to 3.5% in 2019. By eliminating these authorization requirements for buprenorphine, 30% more people will receive treatment for their addiction, and over 50% of deaths from the disorder could be prevented.  Read More

Each Friday, Signor Goat reports the latest from the week in health care. Check back next Friday for your dose of our little medical corner of health care news. Brought to you by pMD, innovators in charge capture, secure messaging, clinical communication, MIPS registry, and care navigation software.

To find out more about pMD's suite of products, which includes our charge capture and MIPS registry, billing services, telehealth, and secure communication software and services, please contact pMD.

Flying notes

Have questions?
We have answers!

Our experienced team is standing by to receive your most pressing inquiries about our solutions and services.
Contact Us
Check these out too!
No items found.